That’s according to new research from The Royal Marsden and The Institute of Cancer Research in Sutton.

Results from their study also suggest that a new AI algorithm could help tailor the treatment of some patients more accurately.

It’s thought the technology could help clinicians diagnose subtypes of the rare disease, speeding up diagnosis as a result.